Skip to content

Clinical trials

Kidney Diseases trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Kidney Diseases Country / region: Brazil Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20073
20081
20111
20122
20154
20172
20191
20201
20213
20221
20235
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Active, not recruiting6
Recruiting4
Unknown status3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
Eli Lilly and Company3
Novartis Pharmaceuticals3
Bayer2
Federal University of São Paulo2
Tanabe Pharma Corporation2
Universidade Federal Fluminense2
Azidus Brasil1
Barretos Cancer Hospital1
Butantan Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Kidney Diseases30
Renal Insufficiency, Chronic15
Diabetes Mellitus, Type 24
Glomerulonephritis4
Cardiovascular Diseases3
Glomerulonephritis, IGA3
Kidney Failure, Chronic3
Urologic Diseases3
Diabetes Mellitus2
Diabetic Nephropathies2

Trials

Showing 76 to 30 of 30. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.